The tonic-clonic seizures treatment market was valued at USD 34.93 billion in 2023. The market is expected to grow at a CAGR of 6% during the period 2024-2032, reaching USD 55.84 billion by 2032. This ...
This page lists all known medications that could potentially lead to 'Tonic-clonic seizures' as a side effect. It's important to note that mild side effects are quite common with medications. The ...
GlaxoSmithKline’s antiseizure drug, Lamictal® (lamotrigine), was approved for a new epilepsy indication—one of the most serious forms of epilepsy, primary generalized tonic-clonic (PGTC) seizures.
-- New approval for VIMPAT® (lacosamide) CV in the U.S. as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures (PGTCS) in patients four years of age and older -- All three ...
LONDON, June 05, 2025--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that 24-month data on generalized tonic-clonic (GTC) seizures in ...
November is Epilepsy Awareness Month. Many people may already be aware of the condition from its prevalence in medical dramas, but that portrayal is often exaggerated and does not fully encapsulate ...
The World Health Organization estimates that more than 50 million people worldwide have some form of epilepsy, a neurological disorder that is characterized by recurring episodes of seizure. While ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results